Centessa Pharmaceuticals plc
Sector: Manufacturing
Industry: Pharmaceutical Products
12.30
0.46
(3.93%)
Volume:
784,645
52 week range:
7.75 - 19.09
Market Cap:
1.407B
Company Description:
Centessa Pharmaceuticals plc discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor. SerpinPC, an activated protein C inhibitor, is in Phase IIa clinical development for the treatment of hemophilia A and B. The company also has emerging pipeline products under clinical proof of concept stage.